| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/11/1996 | WO1996020949A1 Peptide and peptide analog protease inhibitors |
| 07/11/1996 | WO1996020948A1 Human pak65 |
| 07/11/1996 | WO1996020733A1 Treatment of tumors by transduction with negative selective markers, application of interaction agents and subsequent radiation exposure |
| 07/11/1996 | WO1996020732A2 Non-traumatic administration of gene delivery vehicles |
| 07/11/1996 | WO1996020729A1 Decreased mortality of severe acute pancreatitis following proximal cytokine blockade |
| 07/11/1996 | WO1996020728A1 Antitumor agent potentiator comprising il-6 antagonist |
| 07/11/1996 | WO1996020726A1 Urinastatin-containing suppository |
| 07/11/1996 | WO1996020725A2 Peptide, peptide analog and amino acid analog protease inhibitors |
| 07/11/1996 | WO1996020724A1 Generation of human insulin |
| 07/11/1996 | WO1996020723A1 Controlling traf-mediated signals |
| 07/11/1996 | WO1996020721A1 Programmed cell death genes and proteins |
| 07/11/1996 | WO1996020718A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 07/11/1996 | WO1996020709A1 Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals |
| 07/11/1996 | WO1996020698A2 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | WO1996020688A2 Triggered pore-forming agents |
| 07/11/1996 | WO1996015758A3 Methods for stimulating erythropoiesis using thrombopoietin |
| 07/11/1996 | WO1996012508A3 Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy |
| 07/11/1996 | WO1996008565A3 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES |
| 07/11/1996 | CA2209604A1 Functionally active domains of signal transducer and activators of transcription (stat) proteins |
| 07/11/1996 | CA2209526A1 Programmed cell death genes and proteins |
| 07/11/1996 | CA2209234A1 Peptide and peptide analog protease inhibitors |
| 07/11/1996 | CA2209226A1 Polymerase .delta. mutations in colorectal tumors with replication errors |
| 07/11/1996 | CA2208986A1 Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals |
| 07/11/1996 | CA2208699A1 Anti-inflammatory cd14 polypeptides |
| 07/11/1996 | CA2208411A1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/11/1996 | CA2208016A1 Anti-inflammatory cd14 peptides |
| 07/11/1996 | CA2207974A1 Treatment of tumors by transduction with negative selective markers, application of interaction agents and subsequent radiation exposure |
| 07/11/1996 | CA2207961A1 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | CA2207577A1 Purified thrombopoietin and method of making it |
| 07/11/1996 | CA2206479A1 New staphylokinase derivatives |
| 07/11/1996 | CA2205871A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/11/1996 | CA2204731A1 Novel monoclonal antibody having inhibitory activity against type ii phospholipase a2 and protein comprising a part thereof |
| 07/11/1996 | CA2184394A1 Urinastatin-containing suppository |
| 07/10/1996 | EP0721015A1 Monoclonal antibody that induces apoptosis |
| 07/10/1996 | EP0721014A1 Monoclonal antibody that recognizes interstitial cell surface antigen |
| 07/10/1996 | EP0721013A1 New staphylokinase derivatives |
| 07/10/1996 | EP0721012A2 Hyaluronic acid mediated motility receptor (RHAMM) |
| 07/10/1996 | EP0720988A1 Pseudopeptides containing trifluoromethyl substituted 2-azabicyclooctane |
| 07/10/1996 | EP0720987A1 Acylated pseudopeptides containing trifluoromethyl substituted 2-azabicyclooctane |
| 07/10/1996 | EP0720851A2 Medicament for viral inactivation utilizing acridine or acridine derivatives |
| 07/10/1996 | EP0720653A1 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS |
| 07/10/1996 | EP0720652A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 07/10/1996 | EP0720651A1 Nucleic acids encoding merosin, merosin fragments and uses thereof |
| 07/10/1996 | EP0720624A1 Retargeting antibodies |
| 07/10/1996 | EP0720622A1 Interaction of t-cell receptors and antigen in autoimmune disease |
| 07/10/1996 | EP0720621A1 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| 07/10/1996 | EP0720620A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 07/10/1996 | EP0720619A1 Selectin binding glycopeptides |
| 07/10/1996 | EP0720486A1 Peripheralization of hematopoietic stem cells |
| 07/10/1996 | EP0720484A1 Methods and products for controlling immune responses in mammals |
| 07/10/1996 | EP0720483A1 Use of growth hormone for increasement of concentration of gh, igf-i and igfbp-3 in cerebrospinal fluid |
| 07/10/1996 | EP0720482A1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 07/10/1996 | EP0666929A4 Method of inhibiting replication of hyperproliferative cells. |
| 07/10/1996 | EP0628168A4 Method for modulating proopiomelanocortin synthesis in a mammal. |
| 07/10/1996 | EP0457888B1 Octapeptide analogs of somatostatin having threonine at the sixth position |
| 07/10/1996 | CN1126491A Intracellular binding proteins and use thereof |
| 07/10/1996 | CN1126466A Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 07/10/1996 | CN1126441A Amplification of the vitamin B12 uptake system using polymers |
| 07/10/1996 | CN1126440A Stabilized pharmaceutical peptide compositions |
| 07/10/1996 | CN1126439A Compositions for nasal administration of desmopressin |
| 07/10/1996 | CN1126438A Method of combating acyclovir-resistant herpes simplex viral infections |
| 07/10/1996 | CN1126436A Vitamin B12 mediated oral delivery systems for GCSF and EPO |
| 07/10/1996 | CN1032235C Method for producing kedarcidine antitumor chromophore |
| 07/09/1996 | US5534631 Cellular factor ILF |
| 07/09/1996 | US5534621 Immunoaffinity purification methods using single polypeptide chain binding molecules |
| 07/09/1996 | US5534619 Synthetic polypeptides having cationically charged and uncharged segments |
| 07/09/1996 | US5534617 Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 |
| 07/09/1996 | US5534615 Cardiac hypertrophy factor and uses therefor |
| 07/09/1996 | US5534545 Parenteral amino acid formulations for the inhibition of systemic hypotension associated with nitric oxide production |
| 07/09/1996 | US5534540 Crosslinking and discoloration inhibition; preserving foods; aging resistance |
| 07/09/1996 | US5534539 Antitumor agents |
| 07/09/1996 | US5534538 High speed cleavage; artificial nutrition; cell cultures |
| 07/09/1996 | US5534498 Trypsin inhibitors |
| 07/09/1996 | US5534496 Methods and compositions to enhance epithelial drug transport |
| 07/09/1996 | US5534495 Administering linear oligopeptide |
| 07/09/1996 | US5534494 Polypeptide compounds having growth hormone releasing activity |
| 07/09/1996 | US5534493 Use of growth factor IGF-I or IGF-II |
| 07/09/1996 | US5534492 Muramyl peptide for the treatment of toxicity |
| 07/09/1996 | US5534488 Combining zinc with insulin and proteins |
| 07/09/1996 | US5534439 Isolated DNA of human papillomavirus type 55 (HPV55) |
| 07/09/1996 | US5534426 Oncoprotein protein kinase |
| 07/09/1996 | US5534411 Monoclonal IgA antibody specific for respiratory syncytial virus, a hybridoma cell line that produces this antibody amd methods of using the antibody to diagnose RSV infection |
| 07/09/1996 | US5534410 TATA-binding protein associated factors drug screens |
| 07/09/1996 | US5534404 Selecting cells with increased amounts of intracellular free calcium; diabetes reasearch |
| 07/09/1996 | US5534258 Polypeptides to prevent atherosclerotic plaque |
| 07/09/1996 | US5534255 Immunoassay |
| 07/09/1996 | US5534251 Stabilized il-1α medicinal composition |
| 07/09/1996 | US5533836 Compositions and methods for stimulating the growth of osteoblasts |
| 07/09/1996 | CA2000666C Method of making a free-flowing, spray-dried edible powder comprising an oil |
| 07/09/1996 | CA1338453C Purified protein having angiogenic activity and methods of preparation |
| 07/05/1996 | CA2166374A1 Acylated pseudopeptides containing a trifluoromethyl-substituted 2-azabicyclooctane |
| 07/05/1996 | CA2166372A1 Pseudopeptides having a trifluoromethyl-substituted 2-azabicyclooctane |
| 07/04/1996 | WO1996020403A1 Assay, receptor proteins and ligands |
| 07/04/1996 | WO1996020284A1 Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
| 07/04/1996 | WO1996020281A1 Human phosphodiesterase type ivc, and its production and use |
| 07/04/1996 | WO1996020280A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use |
| 07/04/1996 | WO1996020279A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | WO1996020278A2 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| 07/04/1996 | WO1996020277A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 07/04/1996 | WO1996020219A2 Murine monoclonal anti-idiotype antibody 3h1 |